Search

Your search keyword '"Haines, C.J."' showing total 44 results
Start Over Author "Haines, C.J."
44 results on '"Haines, C.J."'

4. Dietary calcium intake in postmenopausal Chinese women

Author

Haines, C.J., Chung, T.K.H., Leung, P.C., Leung, D.H.Y., Wong, M.Y., and Lam, L.L.

Subjects
Postmenopausal women -- Health aspects, Calcium in the body -- Analysis, China -- Health aspects
Abstract

A comparative assessment of dietary calcium in postmenopausal Chinese women and the average Western population reveals that postmenopausal women have a lower dietary intake that is less than the recommended daily allowance for women in East Asia. Low dietary intake of calcium enhances the risk of developing osteoporosis and related fractures. Calcium supplementation has been recommended for this group of postmenopausal women.

Published
1994

7. Menopause management: A cardiovascular risk-based approach.

Author

Haines C.J., Farrell E., Haines C.J., and Farrell E.

Abstract

Hormone replacement therapy (HRT) remains the gold standard for the management of menopausal symptoms; however, HRT use has declined due to concerns over possible adverse side-effects. Approaches to menopause management are continually being revised and these extend beyond the control of recognized menopausal symptoms to encompass wider aspects of menopausal women's health. Hypertension and associated cardiovascular risk are particularly important unmet needs in postmenopausal women, especially in the Asia-Pacific region which has a rapidly aging population and bears around half of the global burden of cardiovascular disease, two-thirds of which has been attributed to elevated blood pressure. As first point of contact for women with menopausal symptoms, gynecologists play a gatekeeper role in assessing women's health, providing appropriate lifestyle counseling, and, where appropriate, implementing treatment or referral to relevant specialists. This paper, with contributions by gynecologists and cardiologists from Asia Pacific and beyond, summarizes available evidence and provides a treatment algorithm that employs a flexible blood pressure classification strategy to assist physicians in their decision-making for the individualized management of menopausal symptoms in women with low, moderate and high cardiovascular risk, and also for women with diabetes. Individualized HRT according to cardiovascular risk may yield improvements in cardiovascular health, as well as managing menopausal symptoms. © 2010 International Menopause Society.

Published
2010

17. P-979

Author

Han, Y., primary, Lam, P., additional, Haines, C.J., additional, and Feng, H., additional

Published
2006
Full Text
View/download PDF

41. Infertility. Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF.

Author

Yim, S.F., Lok, I.H., Cheung, L.P., Briton-Jones, C.M., Chiu, T.T.Y., and Haines, C.J.

Abstract

Gonadotrophin-releasing hormone (GnRH) analogues improve the outcome of treatment with IVF by increasing the number and quality of oocytes retrieved and by reducing cycle cancellation rates. Whilst short-acting GnRH analogues are most commonly used, depot preparations are now available that are more convenient for patient use. Some studies have reported that pregnancy rates with depot GnRH analogues are similar to those of short-acting preparations, but others have suggested that the more profound down-regulation seen with depot GnRH analogues results in inferior embryo quality. The purpose of this study was to determine whether a lower than conventional dose of a depot GnRH analogue may be more appropriate for use in ovarian stimulation prior to IVF. Sixty patients were randomized to receive either 3.75 mg (conventional dose) or 1.87 mg (low dose) triptorelin prior to ovarian stimulation for IVF. Suppression was measured using serum concentrations of LH measured 2 and 3 weeks after the administration of the GnRH analogues, the dose of gonadotrophin used and the time to resumption of menses. Mean concentrations of LH were 2.2 ± 1.0 and 1.1 ± 0.6 IU/l in the conventional dose group and 3.5 ± 5.5 and 2.7 ± 1.9 IU/l in the low dose group (P < 0.05 at 2 and 3 weeks). There were no significant differences between the doses of gonadotrophins used, the number of oocytes and embryos available and the time to resumption of menses, nor in the pregnancy rates. Although the degree of suppression as measured biochemically was more profound with the conventional dose, this did not affect the IVF outcome. The use of a lower dose therefore appears to be equally effective and could contribute to a reduction in the cost of treatment. [ABSTRACT FROM PUBLISHER]

Published
2001
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results